Resources

Type of publications
Regions
Diseases

5192 results found

2025 ∙ Hirsch, C. Zorger, A. M. Baumann, M. Park, Y. S. Bröckelmann, P. J. Mellinghoff, S. Monsef, I. Skoetz, N. Kreuzberger, N.

Vaccines for preventing infections in adults with solid tumours

  • Adults
  • Older adults
  • Pneumococcal disease
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Pertussis
  • Hepatitis B
  • Tetanus
  • Poliomyelitis
  • Diphtheria
  • Influenza
  • Herpes zoster
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
High
2025 ∙ de Bondt, D. Naslazi, E. Jansen, E. Kupets, R. McCurdy, B. Stogios, C. de Kok, I. Hontelez, J.

Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies

  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Coverage
  • Modeling
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Bolormaa, E. Lee, Y. H. Choe, Y. J. Choe, S. A.

Varicella Vaccine Effectiveness and Duration of Protection: A Systematic Review and Meta-Analysis

  • All age groups
  • Varicella
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Dobritoiu, R. Pacurar, D. Vlad, R. M. Plesca, D. A.

Vertical Transmission of Hepatitis B and C-Then and Now-A Comprehensive Literature Systematic Review

  • Pregnant women
  • Newborn
  • Hepatitis B
  • Hepatitis C
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Riches, N. Henrion, M. Y. R. MacPherson, P. Hahn, C. Kachala, R. Mitchell, T. Murray, D. Mzumara, W. Nkoka, O. Price, A. J. Riches, J. Seery, A. Thom, N. Loarec, A. Lemoine, M. Ndow, G. Shimakawa, Y. Thompson, P. Morgan, C. Desai, S. Easterbrook, P. Stockdale, A. J.

Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis

  • Africa
  • Pregnant women
  • Newborn
  • Hepatitis B
  • Efficacy/effectiveness
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Hemrajani, P. Sharma, M. Gupta, S.

Vitiligo and coronavirus disease 2019 vaccination: A systematic review

  • All age groups
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Ahmed, A. Cahn, B. Haber, R.

Wells syndrome: emerging triggers and treatments- an updated systematic review

  • All age groups
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.

Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis

  • Western Pacific
  • China
  • All age groups
  • Economic aspects
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025

Decision-maker needs for modelling: findings from a qualitative study

  • NITAG training
2025 ∙ WHO

WHO position paper on Pneumococcal conjugate vaccines in infants and children aged <5 years – September 2025

  • Position paper
  • Pneumococcal disease
Download:
Loading...